VAERS reports by lot

Moderna COVID-19 lot 042B21-2A: VAERS reports

144 VAERS reports list lot 042B21-2A as a Moderna COVID-19 vaccine, received between 2021-04-13 and 2023-12-14. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
144
Reports
16%
Marked serious
5
With a death outcome
18
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)12621%
Neurological11519%
Cardiac / Cardiovascular7112%
Injection-site / Local reaction6110%
Gastrointestinal549%
Musculoskeletal427%
Dermatological (non-injection-site)396%
Respiratory386%
Allergic / Anaphylactic285%
Psychiatric / Neuropsychiatric112%
Thrombotic / Hematological81%
Autoimmune / Immune-mediated81%
Reproductive / Menstrual51%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois37
New Hampshire15
Massachusetts14
Kentucky13
California10
West Virginia9
South Carolina8
Rhode Island6
Ohio3
Tennessee3
Delaware2
New Jersey2

Reports by month received

2021-0457
2021-0524
2021-069
2021-077
2021-088
2021-093
2021-1010
2021-116
2021-124
2022-015
2022-022
2022-033
2022-061
2022-091
2022-111
2023-081
2023-091
2023-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.